Table 1.
Reported colorectal cancer with rhabdoid features (N = 28)
| No | Author | Year | Age | Gender | Site | Size (cm) | Treatment | Histology | Outcome | Metastasis | INI1 expression | RAS, BRAF, MSI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Chetty et al. [13] | 1993 | 72 | M | Cecum | 6 × 5x2 | Surgery | Composite | Dead 3 mo | Liver, LN | ND | ND |
| 2 | Yang et al. [14] | 1994 | 75 | M | Transverse | 15 × 10x5 | Surgery | Pure | Dead 0.5 mo | LN | ND | ND |
| 3 | Macak et al. [15] | 1995 | 50 | M | Transverse | 6 × 5x3.5 | Surgery | Composite | Not reported | LN | ND | ND |
| 4 | Marcus et al. [16] | 1996 | 84 | F | Transverse | 7 | Surgery | Pure | Dead 3 mo | None | ND | KRAS, NRAS, HRAS WT |
| 5 | Nakamura et al. [17] | 1999 | 76 | M | Cecum | 14 × 8x6 | Surgery | Pure | Dead 3 mo | Liver, LN | ND | ND |
| 6 | Horie et al. [18] | 2000 | 76 | M | Rectum | NS | NS | Composite | NS | Liver | ND | ND |
| 7 | Hamada et al. [19] | 2004 | 65 | F | Rectum | 13 × 8 | Surgery | Pure | Alive 10 mo | Lung | ND | ND |
| 8 | Nakayama et al. [20] | 2005 | 63 | M | Rectum | 10 × 8.4 | Surgery | Pure | Alive 12 mo | LN | ND | ND |
| 9 | Matsunuma et al. [21] | 2005 | 54 | M | Ascending | 11 × 9.5 | Surgery | Pure | Dead 2 mo | None | ND | ND |
| 10 | Yamaguchi et al. [22] | 2006 | 72 | F | Descending | 10 × 8.5 | Surgery,CT | Composite | Dead 1.5 mo | Peritoneum, nodes | ND | ND |
| 11 | Kono et al. [5] | 2007 | 66 | M | Cecum | 13 × 13 | Surgery | Composite | Dead 1.5 mo | LN | ND | KRAS WT, MSS |
| 12 | Mastoraki et al. [23] | 2009 | 62 | F | Descending | 8 × 10x8 | Surgery | Pure | Dead 4 mo | Liver | ND | RAS family WT |
| 13 | Han et al. [24] | 2010 | 23 | F | Rectum | 6 × 5 | Surgery,CT,RT | Pure | Alive 17 mo | None | ND | ND |
| 14 | Pancione et al. [25] | 2011 | 71 | F | Asecnding | 10 × 10 | Surgery,CT | Pure | Dead 8 mo | Liver, peritoneum, LN | ND | BRAFV600E |
| 15 | Takeshita et al. [26] | 2011 | 75 | M | Rectum | 17 × 10 | Surgery,CT | Pure | Dead 5 mo | LN | ND | ND |
| 16 | Remo et al. [27] | 2012 | 73 | F | Ascending | 10 × 4 | Surgery,CT | Composite | Dead 6 mo | LN | negative | BRAF600VE |
| 17 | Kobayashi et al. [28] | 2012 | 58 | F | Ascending | 10 × 5 | Surgery | Composite | Dead 4 mo | LN | positive | ND |
| 18 | Lee JR et al. [29] | 2013 | 62 | M | Sigmoid | 4 × 4x1 | Surgery,CT | Composite | Alive 36 mo | LN | ND | ND |
| 19 | Samalavicius et al. [30] | 2013 | 49 | M | Rectum | 7 | Surgery,CT | Pure | Dead 7 mo | LN | positive | KRAS WT, BRAF600VE |
| 20 | Saito et al. [31] | 2014 | 81 | M | Cecum | 8 × 6 | Surgery,CT | Composite | Dead 0.7 mo | Liver, LN | ND | ND |
| 21 | Baba et al. [32] | 2014 | 45 | F | Sigmoid | 9 × 8x5 | Surgery | Composite | Dead 1.5 mo | Peritoneum, lung, LN | ND | ND |
| 22 | Romera et al. [33] | 2014 | 77 | M | Descending | - | Surgery | Pure | Dead 2 mo | None | ND | ND |
| 23 | Agaimy et al. [1] | 2014 | 79 | M | Cecum | 9 × 5x2 | Surgery | Pure | Dead 6 mo | LN | negative | BRAFV600E |
| 24 | Cho et al. [12] | 2015 | 73 | M | Cecum | 4 × 3 | Surgery | Composite | Alive 1 mo | LN | ND | KRAS WT, BRAF600E |
| 25 | Moussaly et al. [34] | 2015 | 87 | F | Transverse | 12 × 9.5x8.5 | Surgery | Composite | Dead 2 mo | None | ND | ND |
| 26 | Kalyan et al. [35] | 2015 | 31 | F | Cecum | 7 | Surgery,CT | Composite | Dead 4 mo | LN | positive | KRAS mutant, BRAF WT |
| 27 | D'Amico et al. [36] | 2019 | 65 | M | Ascending | 10 | Surgery | Pure | Alive 48 mo | LN | negative | ND |
| 28 | This study | 2019 | 41 | M | Sigmoid | 7 × 6 | Surgery,CT | Pure | Dead 2 mo | Liver, peritoneum, LN | negative | RAS WT, BRAFV600E, MSS |
CT chemotherapy, RT radiotherapy, mo month, LN lymph node, NS not specified, ND not done, WT wild type, MSI microsatellite instability, MSS micorosatellite stable